Chemomab Therapeutics Ltd.

Company name

Website

Start date

End date

Ticker

Listed market

NASDAQ

Country

United States of America

Business activities

Fibro-inflammatory disease therapeutics

Monoclonal antibody development

Clinical-stage drug development

Clinical trials

Head office

10 Habarzel Street, Building C, 10th Floor, Tel Aviv 6158101, Israel

Chief executive

Adi Mor

Employees (non-consolidated)

Employees (consolidated)

Related companies

Company name

Group Parent Subsidiary Customer Supplier Alliance Bank Shareholder

Relationship graph

History

1 entries

Date	Description
2011

News

+ Loaded when opened

Data sources

News pages

Own domain

✅

Last updated

2026-09-21 18:15 (Model: )